Literature DB >> 11022777

Long-term treatment with subantimicrobial dose doxycycline exerts no antibacterial effect on the subgingival microflora associated with adult periodontitis.

C Walker1, J Thomas, S Nangó, J Lennon, J Wetzel, C Powala.   

Abstract

BACKGROUND: The purpose of this study was to determine whether treatment with subantimicrobial dose doxycycline (SDD), 20 mg bid, exerted an antimicrobial effect on the microflora associated with adult periodontitis.
METHODS: Following the approval of the protocol and informed consent forms by the respective IRBs at the University of Florida and West Virginia University, 76 subjects with adult periodontitis were entered and randomly assigned to receive SDD or placebo. A split-mouth design was utilized, with each subject receiving subgingival scaling and root planing (SRP) in two quadrants immediately following baseline data collection, while the remaining two quadrants were left unscaled (non-SRP). Microbial samples were collected prior to treatment, after 3, 6, and 9 months of treatment, and after 3 months of no treatment. The samples were examined by microscopy and by enumeration on selective and non-selective media.
RESULTS: All treatments resulted in statistically significant decreases in the proportions of spirochetes and motile rods (P <0.05) and in an increase in the proportion of coccoid forms (P <0.0001) relative to baseline. No between-treatment differences were detected between the SDD and placebo treatments in either the SRP or non-SRP design, with the exception of the small and large spirochetal groups. The spirochetal proportions present in the SDD group were significantly lower (P<0.05) than the paired placebo group during the 9-month treatment and was preceded by a significant decrease (P<0.01) in the proportion of microbiologic sample sites that bled on probing. No between- treatment differences were detected in any of the other microbial parameters.
CONCLUSION: The microbial differences observed were attributed to the anticollagenase and anti-inflammatory properties of SDD and not to an antimicrobial effect.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11022777     DOI: 10.1902/jop.2000.71.9.1465

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  8 in total

1.  Sub-antimicrobial doxycycline for periodontitis reduces hemoglobin A1c in subjects with type 2 diabetes: a pilot study.

Authors:  Steven P Engebretson; Judith Hey-Hadavi
Journal:  Pharmacol Res       Date:  2011-07-19       Impact factor: 7.658

2.  Effect of systemic matrix metalloproteinase inhibition on periodontal wound repair: a proof of concept trial.

Authors:  R Gapski; J L Barr; D P Sarment; M G Layher; S S Socransky; W V Giannobile
Journal:  J Periodontol       Date:  2004-03       Impact factor: 6.993

3.  Subantimicrobial dose doxycycline effects on osteopenic bone loss: microbiologic results.

Authors:  Clay Walker; Susan Puumala; Lorne M Golub; Julie A Stoner; Richard A Reinhardt; Hsi-Ming Lee; Jeffrey B Payne
Journal:  J Periodontol       Date:  2007-08       Impact factor: 6.993

Review 4.  Can tetracyclines ensure help in multiple sclerosis immunotherapy?

Authors:  Pedro Víctor-Carvalho; Rodolfo Thome; Catarina Rapôso
Journal:  J Clin Transl Res       Date:  2021-02-03

5.  The effect of doxycycline on canine hip osteoarthritis: design of a 6-months clinical trial.

Authors:  Korakot Nganvongpanit; Peraphan Pothacharoen; Niyada Suwankong; Siriwan Ong-Chai; Prachya Kongtawelert
Journal:  J Vet Sci       Date:  2009-09       Impact factor: 1.672

6.  Non-antibacterial tetracycline formulations: clinical applications in dentistry and medicine.

Authors:  Ying Gu; Clay Walker; Maria E Ryan; Jeffrey B Payne; Lorne M Golub
Journal:  J Oral Microbiol       Date:  2012-10-12       Impact factor: 5.474

Review 7.  Non-antibacterial tetracycline formulations: host-modulators in the treatment of periodontitis and relevant systemic diseases.

Authors:  Lorne M Golub; Muna S Elburki; Clay Walker; Maria Ryan; Timo Sorsa; Howard Tenenbaum; Michael Goldberg; Mark Wolff; Ying Gu
Journal:  Int Dent J       Date:  2016-03-23       Impact factor: 2.607

8.  A regulatable AAV vector mediating GDNF biological effects at clinically-approved sub-antimicrobial doxycycline doses.

Authors:  Abdelwahed Chtarto; Marie Humbert-Claude; Olivier Bockstael; Atze T Das; Sébastien Boutry; Ludivine S Breger; Bep Klaver; Catherine Melas; Pedro Barroso-Chinea; Tomas Gonzalez-Hernandez; Robert N Muller; Olivier DeWitte; Marc Levivier; Cecilia Lundberg; Ben Berkhout; Liliane Tenenbaum
Journal:  Mol Ther Methods Clin Dev       Date:  2016-03-30       Impact factor: 6.698

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.